Räikkönen K, Pesonen A-K, O'Reilly J R, Tuovinen S, Lahti M, Kajantie E, Villa P, Laivuori H, Hämäläinen E, Seckl J R, Reynolds R M
Institute of Behavioral Sciences,University of Helsinki,Helsinki,Finland.
Endocrinology Unit,University/BHF Centre for Cardiovascular Science,Queen's Medical Research Institute,Edinburgh,UK.
Psychol Med. 2015 Nov;45(15):3217-26. doi: 10.1017/S003329171500121X. Epub 2015 Jun 22.
Glucocorticoids and serotonin may mediate the link between maternal environment, fetal brain development and 'programming' of offspring behaviors. The placenta regulates fetal exposure to maternal hormonal signals in animal studies, but few data address this in humans. We measured prospectively maternal depressive symptoms during pregnancy and mRNAs encoding key gene products determining glucocorticoid and serotonin function in term human placenta and explored associations with infant regulatory behaviors.
Bi-weekly self-ratings of the Center for Epidemiologic Studies Depression Scale from 12th to 13th gestational week onwards and term placental mRNAs of 11beta-hydroxysteroid dehydrogenase type 2 (HSD2B11), type 1 (HSD1B11), glucocorticoid (NR3C1), mineralocorticoid receptors (NR3C2) and serotonin transporter (SLC6A4) were obtained from 54 healthy mothers aged 32.2 ± 5.3 years with singleton pregnancies and without pregnancy complications. Infant regulatory behaviors (crying, feeding, spitting, elimination, sleeping and predictability) were mother-rated at 15.6 ± 4.2 days.
Higher placental mRNA levels of HSD2B11 [0.41 standard deviation (s.d.) unit increase per s.d. unit increase; 95% confidence interval (CI) 0.13-0.69, p = 0.005], HSD1B11 (0.30, 0.03-0.57, p = 0.03), NR3C1 (0.44, 0.19-0.68, p = 0.001) and SLC6A4 (0.26, 0.00-0.53, p = 0.05) were associated with more regulatory behavioral challenges of the infant. Higher placental NR3C1 mRNA partly mediated the association between maternal depressive symptoms during pregnancy and infant regulatory behaviors (p < 0.05).
Higher placental expression of genes regulating feto-placental glucocorticoid and serotonin exposure is characteristic of infants with more regulatory behavioral challenges. Maternal depression acts, at least partly, via altering glucocorticoid action in the placenta to impact on offspring regulatory behaviors.
糖皮质激素和血清素可能介导母体环境、胎儿大脑发育与后代行为“编程”之间的联系。在动物研究中,胎盘可调节胎儿对母体激素信号的暴露,但在人类中相关数据较少。我们前瞻性地测量了孕期母体的抑郁症状,以及足月人胎盘中编码决定糖皮质激素和血清素功能的关键基因产物的mRNA,并探讨了其与婴儿调节行为的关联。
从妊娠第12至13周起,每两周进行一次流行病学研究中心抑郁量表的自我评分,并从54名年龄为32.2±5.3岁、单胎妊娠且无妊娠并发症的健康母亲中获取足月胎盘的11β-羟类固醇脱氢酶2型(HSD2B11)、1型(HSD1B11)、糖皮质激素受体(NR3C1)、盐皮质激素受体(NR3C2)和血清素转运体(SLC6A4)的mRNA。在婴儿15.6±4.2日龄时,由母亲对婴儿的调节行为(哭闹、进食、吐奶、排泄、睡眠和可预测性)进行评分。
胎盘HSD2B11(每标准差单位增加,mRNA水平增加0.41标准差单位;95%置信区间[CI] 0.13 - 0.69,p = 0.005)、HSD1B11(0.30,0.03 - 0.57,p = 0.03)、NR3C1(0.44,0.19 - 0.68,p = 0.001)和SLC6A4(0.26,0.00 - 0.53,p = 0.05)的mRNA水平较高与婴儿更多的调节行为挑战相关。胎盘NR3C1 mRNA水平较高部分介导了孕期母体抑郁症状与婴儿调节行为之间的关联(p < 0.05)。
调节胎儿 - 胎盘糖皮质激素和血清素暴露的基因在胎盘中的较高表达是具有更多调节行为挑战的婴儿的特征。母体抑郁至少部分通过改变胎盘中的糖皮质激素作用来影响后代的调节行为。